Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: The Cigna Group, 3 years.
The Cigna Group
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
The Cigna Group April 22, 202699.3%
-
The Cigna Group April 22, 202599.8%
-
The Cigna Group April 24, 202499.8%
-
The Cigna Group April 26, 202399.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | The Charles Schwab Corporation | Option exercise | +5,000 | $64.10 | $320,500 |
| Nov 2, 2026 | The Charles Schwab Corporation | Open-market sale | −5,000 | $88.92 | $444,618 |
| Oct 1, 2026 | The Charles Schwab Corporation | Option exercise | +5,000 | $41.98 | $209,900 |
| Oct 1, 2026 | The Charles Schwab Corporation | Open-market sale | −5,000 | $97.80 | $489,007 |
| Sep 1, 2026 | The Charles Schwab Corporation | Option exercise | +3,177 | $52.05 | $165,363 |
| Sep 1, 2026 | The Charles Schwab Corporation | Open-market sale | −3,177 | $109.04 | $346,420 |
| Aug 28, 2026 | The Charles Schwab Corporation | Option exercise | +3,177 | $52.05 | $165,363 |
| Aug 28, 2026 | The Charles Schwab Corporation | Open-market sale | −3,177 | $108.12 | $343,497 |
| Apr 22, 2026 | The Cigna Group | Grant or award | +782 | — | — |
| Apr 23, 2025 | The Cigna Group | Grant or award | +638 | — | — |
| Apr 24, 2024 | The Cigna Group | Grant or award | +539 | — | — |
| Apr 26, 2023 | The Cigna Group | Grant or award | +765 | — | — |
Questions about Neesha Hathi
What boards is Neesha Hathi on?
Neesha Hathi sits on the board of The Cigna Group.
How long has Neesha Hathi served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.